CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3,697 enrolled
Drug / intervention
i-STAT hs-TnI Cartridge Testing on i-STAT 1 and i-STAT Alinityother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05629572
NCT05629572N/ACompleted

Clinical Evaluation of the i-STAT High Sensitivity Troponin I Test to Aid in the Diagnosis of Myocardial Infarction (MI)

Abbott Point of Care·observational·Posted Nov 29, 2022·Updated Sep 19, 2024

In Brief

An observational study evaluating i-STAT hs-TnI Cartridge Testing on i-STAT 1 and i-STAT Alinity for Myocardial Infarction. Completed, enrolled 3,697 participants across 28 sites.

Detailed Summary

The goal of this observational multi-center study is to evaluate the clinical performance of the i-STAT hs-TnI test (i-STAT High Sensitivity Troponin I) using the investigational i-STAT hs-TnI cartridge for the proposed intended use as an aid in the diagnosis and treatment of myocardial infarction (MI). The cartridge measures cardiac troponin I (cTnI) in whole blood or plasma samples using the i-STAT 1 Analyzer or i-STAT Alinity Instrument. Subjects presenting to the emergency department (ED) with chest discomfort or equivalent ischemic symptoms suggestive of Acute Coronary Syndrome (ACS) who are enrolled in this study will be asked to provide blood samples for testing.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedNov 29, 2022
Enrollment StartNov 2, 2022
Primary CompletionFeb 6, 2024
Study CompletionMar 11, 2024
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 3.6 years ago

Interventions

i-STAT hs-TnI Cartridge Testing on i-STAT 1 and i-STAT Alinityother

Paired whole blood and plasma samples collected at multiple time points.